A great post by Core EM - Bringing core EM content to anyone, anywhere, anytime. Learn the HIET for beta-blocker and calcium-channel-blocker toxicity by Dr. Jenny Beck-Esmay, MD (@jbeckesmay)
A focused update on poisonings, toxicologic emergencies, and toxidromes with pearls, pitfalls, and myths. What can the emergency physician miss?
From the understanding of physostigmine’s mechanism of action and the above data, we would like to summarize key points and recommendations regarding the use of physostigmine.
Our ongoing intern report series is the product of first-year EM residents at UT Southwestern exploring clinical questions they have found to be particularly intriguing. For med students & junior residents – if you haven’t encountered these issues yet, you will!
"The lack of high-quality controlled human studies precludes ILE as a first-line agent for indications other than local anesthetic systemic toxicity"Thanks to James Cao, MD for this excellent review of the literature on the use of ILE therapy in various toxicologic emergencies.
"The delayed phase consists of cns and respiratory depression, dyspnea, bradycardia, hypotension, shock, mydriasis, weakness, muscle paralysis, and coma"We are very pleased to present you with this overview on the potential dangers of electronic cigarettes and liquid nicotine from the toxicologists at UT Southwestern.
"There have been a growing number of cases associated with life-threatening neurotoxic effects and cardiotoxic effects"Cynthia Santos, MD gives a nice overview of the increasingly popular synthetic cannabinoids, including the range of clinical presentations, management, and the bottom line for your practice in the ED.
"Think about these substances in a patient with either an opioid, sympathomimetic, or hallucinogenic toxidrome"
Alex Koyfman, MD summarizes the assorted clinical presentations of these three "legal" highs.
